Tags

Type your tag names separated by a space and hit enter

[Clinical analysis of intravenous-cardiac leiomyomatosis].
Zhonghua Yi Xue Za Zhi. 2020 Jun 09; 100(22):1741-1744.ZY

Abstract

Objective:

To summarize the clinical characteristics, treatment and prognosis of patients with right intravenous-cardiac leiomyomatosis, and provide references for clinical diagnosis and management.

Methods:

The clinical data of 22 patients who were admitted to Department of Cardiac Surgery in Beijing Anzhen Hospital from November 2009 to July 2019 were retrospectively reviewed. The long-term prognosis of the patients was also evaluated.

Results:

All patients were women, with an age of (48.1±6.3) years. The clinical manifestations of patients lacked specificity. Among them, 14 patients had a history of uterine leiomyoma, 12 had hysterectomy, and 5 had abortions. Twenty patients underwent tumor resection. One-stage operation was performed in 15 cases, while staging surgery was performed in 5 cases. Ten cases underwent tumor resection under cardiopulmonary bypass. One case underwent a tricuspid valve annuloplasty at the same time. There was no death early in postoperative period. Early complications included deep venous thrombosis (2 cases), type Ⅱ atrioventricular block (1 case), pleural effusion (1 case) and incision infection (1 case). In the long-term follow-up (3 years), one case died of tumor recurrence-associated circulatory failure. Among the rest of the patients, the quality of life was satisfying, and cardiac function was between grade Ⅰ and Ⅱ, with no recurrence or metastasis.

Conclusions:

Patients with intravenous-cardiac leiomyomatosis are lack of specific manifestations. Early diagnosis is crucial for the treatment of this disease. Tumor resection is an effective treatment, which can improve the quality of life and long-term survival of patients.

Authors+Show Affiliations

Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.

Pub Type(s)

English Abstract
Journal Article

Language

chi

PubMed ID

32536097

Citation

Zhao, Y, et al. "[Clinical Analysis of Intravenous-cardiac Leiomyomatosis]." Zhonghua Yi Xue Za Zhi, vol. 100, no. 22, 2020, pp. 1741-1744.
Zhao Y, Huang ZH, Fu W, et al. [Clinical analysis of intravenous-cardiac leiomyomatosis]. Zhonghua Yi Xue Za Zhi. 2020;100(22):1741-1744.
Zhao, Y., Huang, Z. H., Fu, W., Liu, T. S., & Dong, R. (2020). [Clinical analysis of intravenous-cardiac leiomyomatosis]. Zhonghua Yi Xue Za Zhi, 100(22), 1741-1744. https://doi.org/10.3760/cma.j.cn112137-20191212-02707
Zhao Y, et al. [Clinical Analysis of Intravenous-cardiac Leiomyomatosis]. Zhonghua Yi Xue Za Zhi. 2020 Jun 9;100(22):1741-1744. PubMed PMID: 32536097.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Clinical analysis of intravenous-cardiac leiomyomatosis]. AU - Zhao,Y, AU - Huang,Z H, AU - Fu,W, AU - Liu,T S, AU - Dong,R, PY - 2020/6/16/entrez KW - Heart neoplasms KW - Intravenous-cardiac leimyomatosis KW - Prognosis SP - 1741 EP - 1744 JF - Zhonghua yi xue za zhi JO - Zhonghua Yi Xue Za Zhi VL - 100 IS - 22 N2 - Objective: To summarize the clinical characteristics, treatment and prognosis of patients with right intravenous-cardiac leiomyomatosis, and provide references for clinical diagnosis and management. Methods: The clinical data of 22 patients who were admitted to Department of Cardiac Surgery in Beijing Anzhen Hospital from November 2009 to July 2019 were retrospectively reviewed. The long-term prognosis of the patients was also evaluated. Results: All patients were women, with an age of (48.1±6.3) years. The clinical manifestations of patients lacked specificity. Among them, 14 patients had a history of uterine leiomyoma, 12 had hysterectomy, and 5 had abortions. Twenty patients underwent tumor resection. One-stage operation was performed in 15 cases, while staging surgery was performed in 5 cases. Ten cases underwent tumor resection under cardiopulmonary bypass. One case underwent a tricuspid valve annuloplasty at the same time. There was no death early in postoperative period. Early complications included deep venous thrombosis (2 cases), type Ⅱ atrioventricular block (1 case), pleural effusion (1 case) and incision infection (1 case). In the long-term follow-up (3 years), one case died of tumor recurrence-associated circulatory failure. Among the rest of the patients, the quality of life was satisfying, and cardiac function was between grade Ⅰ and Ⅱ, with no recurrence or metastasis. Conclusions: Patients with intravenous-cardiac leiomyomatosis are lack of specific manifestations. Early diagnosis is crucial for the treatment of this disease. Tumor resection is an effective treatment, which can improve the quality of life and long-term survival of patients. SN - 0376-2491 UR - https://www.unboundmedicine.com/medline/citation/32536097/[Clinical_analysis_of_intravenous-cardiac_leiomyomatosis] L2 - http://journal.yiigle.com/LinkIn.do?linkin_type=pubmed&DOI=10.3760/cma.j.cn112137-20191212-02707 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.